![Jeffrey S. Price](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey S. Price
Chief Executive Officer at Octamer, Inc.
Profile
Jeffrey S.
Price is currently the Chief Executive Officer, CFO & Director at Octamer, Inc. and the Chairman at Planet Biotechnology, Inc. He previously served as the Director-Supervisory Board at PanGenetics BV and as the Senior Vice President-Research & Development at Cetus Corp.
Jeffrey S. Price active positions
Companies | Position | Start |
---|---|---|
Octamer, Inc.
![]() Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Chief Executive Officer | - |
Planet Biotechnology, Inc.
![]() Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Chairman | 1997-12-31 |
Former positions of Jeffrey S. Price
Companies | Position | End |
---|---|---|
Cetus Corp. | Chief Tech/Sci/R&D Officer | - |
PanGenetics BV
![]() PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
PanGenetics BV
![]() PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
Octamer, Inc.
![]() Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Health Technology |
Cetus Corp. | Health Technology |
Planet Biotechnology, Inc.
![]() Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey S. Price